Abstract:Background: In the past two decades, a large-scale survey of hemoglobinopathies and thalassemia was carried out in mainland China, involving nearly one million people in 28 provinces. The incidences of hemoglobin (Hb) variants, α-thalassemia and β-thalassemia were 0.33%, 2.64% and 0.66%, respectively. The chemical structural analysis identified 67 Hb variants. Among them, 20 are new variants. The analysis of the α-globin gene organization in 111 HbH patients showed 76 cases (68.5%) were of the deletion type, 8 had Hb Constant Spring and the other cases were of non-deletion type. The results of the molecular characterization of more than 200 β-thalassemia alleles showed that the most common types of β-thalassemia mutations in China are CD 41/42 (−4 bp), IVS-II-nt.654 C→T, CD 17 A→T, CD 71/72 (+A) and −28 A→G. Methods: To explore the simple method for molecular diagnosis of β-thalassemia, multiplex allele-specific amplification (MAS-PCR) was used that could simultaneously detect the above five common types of β-thalassemia mutations. Results: Based on the molecular analysis of β-thalassemia intermedia, β-thalassemia homozygotes or compound heterozygotes combined with α-thalassemia, as well as the conjunctive abnormalities of β-thalassemia heterozygote with triplicated haplotype of α-globin genes, were the most common cause of thalassemia intermedia in China. We also used the RT-PCR quantitation method to show that the most common β-thalassemia allele, IVS-II-nt.654 C→T, still produced a small amount (about 15%) of normally spliced β-globin mRNA, therefore, causing β+-thalassemia. In clinical trials of hydroxyurea (HU) treatment for β-thalassemia patients, we found that HU may enhance the expression of the β-globin gene in some patients, leading to an alleviation of clinical symptoms. In the studies of the reversal of aberrant splicing of IVS-II-nt.654 C→T allele by the antisense approach, we constructed a mammalian expression vector that can produce an antisense RNA targeting against the aberrant splice sites of IVS-II-nt.654 C→T pre-mRNA. Conclusions: The results indicated that the antisense RNA produced from the vector could efficiently suppress the aberrant splicing pattern and restore the correct splicing pathway in vitro and in vivo, leading to the improvement of globin chain biosynthesis in thalassemia cells.

Alpha-globin gene organisation and prenatal diagnosis of alpha-thalassaemia in Chinese.

Α-Globin GENE ORGANISATION AND PRENATAL DIAGNOSIS OF Α-Thalassaemia IN CHINESE

Prevention of Hb Bart’s (γ4) Disease Associated with the – –Thaiα0-Thalassemia Deletion in Mainland China

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Molecular analysis of alpha/beta-thalassemia in a southern Chinese population.

Prenatal Diagnosis of Thalassemia: Experiences at the Shanghai Children's Hospital.

Detection of alpha-thalassemia in China by using multiplex ligation-dependent probe amplification

Molecular Analysis of α/β-Thalassemia in A Southern Chinese Population

The carriage rates of <SUP>anti3.7</SUP>, <SUP>anti4.2</SUP>, and HK in the population of Guangxi, China measured using a rapid detection qPCR system to determine CNV in the -globin gene cluster

Invasive Molecular Prenatal Diagnosis of Alpha and Beta Thalassemia among Hakka Pregnant Women

The Prevalence and Spectrum of Alpha and Beta Thalassaemia in Guangdong Province: Implications for the Future Health Burden and Population Screening

Prenatal diagnosis of beta-thalassemia by reverse dot-blot hybridization in southern China

Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China

Analysis of deletional hereditary persistence of fetal hemoglobin/δβ-thalassemia and δ-globin gene mutations in Southerwestern China

Disorders of Haemoglobin in China.

A Pilot Study of Noninvasive Prenatal Diagnosis of Alpha- and Beta-Thalassemia with Target Capture Sequencing of Cell-Free Fetal DNA in Maternal Blood

Molecular characterization of hemoglobinopathies and thalassemias in Northern Guangdong Province, China

The Studies of Hemoglobinopathies and Thalassemia in China--the Experiences in Shanghai Institute of Medical Genetics.

Identification of a novel 145 kb deletion (Guigang deletion, -Guigang) in the alpha-globin gene cluster from a Chinese newborn using third-generation sequencing

The pedigree analysis and prenatal diagnosis of Hong Kongαα Thalassemia and the sequence analysis of Hong Kongαα Allele

Hb H disease associated with compound heterozygosity for --SEA deletion and a novel alpha globin chain variant (HBA2:c.175C>A) on the distal histidine in a Chinese family